Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph phase_2
1
33%
Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Other(2)

Detailed Status

unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 21 (50.0%)
N/A1 (50.0%)

Trials by Status

recruiting133%
unknown267%

Recent Activity

1 active trials
Showing 3 of 3
recruiting

Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

NCT03019757
unknownphase_2

Modeling the Relationships Between Functional Connectivity and Amyloid Deposition in Alzheimer's Disease

NCT04174287
unknownnot_applicable

Establish Taiwan Alzheimer's Disease Neuroimaging Initiative - a Three-year Pilot Study

NCT01624389

Clinical Trials (3)

Showing 3 of 3 trials
NCT03019757

Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

Recruiting
NCT04174287Phase 2

Modeling the Relationships Between Functional Connectivity and Amyloid Deposition in Alzheimer's Disease

Unknown
NCT01624389Not Applicable

Establish Taiwan Alzheimer's Disease Neuroimaging Initiative - a Three-year Pilot Study

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3